Posts for the 'News & Alerts' Category
DePuy ASR Hip Recall Lawyers: Sales Halted Amid Reports of Hip Failure
DePuy Orthopedics, a division of Johnson & Johnson, has agreed to remove the DePuy ASR metal-on-metal hip implant from the market. While the manufacturer initially maintained that the relatively new device was being discontinued due to slowing sales, they acknowledged last week that a number of patients have experienced higher-than-expected hip failure with the artificial implant.
>>INFORMATION: DePuy ASR Hip Lawsuits
Plavix Lawsuit: Black Box Warning Indicates Drug Ineffective in Some Patients
The FDA has announced a “black box” Plavix warning, indicating that the anti-clotting medication may be ineffective in some patients with a genetic variation. This could cause an individual at risk for a heart attack, stroke, angina or cardiovascular death to suffer a serious and potentially life-threatening injury.
St. Joseph Stent Letter Sent to 169 More Patients of Dr. Mark Midei
St. Joseph Medical Center has confirmed that it sent 169 more letters last month to patients who may have undergone unnecessary coronary stent implant surgery. While we have seen an increase in calls from individuals who recently received a St. Joseph stent letter, a report in the Baltimore Business Journal confirms that the hospital has now sent letters to a total of 529 patients informing them that they may have been victims of unneeded stents by Dr. Mark Midei.
>>INFORMATION: St. Joseph Stent Surgery Lawsuits
Fosamax Fracture Lawyers:
Reports of Unexplained Broken Bones from Fosamax
The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the United States who have suffered a femur fracture from Fosamax. Recent media reports have drawn substantial attention to this potential Fosamax side effect, which Merck & Co. has failed to adequately warn users about.
>>INFORMATION: Fosamax Fracture Lawsuits
Fosamax (alendronate sodium) is an osteoporosis drug prescribed millions of people to reduce the risk of fractures, primarily involving the hip. About 1,000 Fosamax lawsuits have already been filed by users of this drug who experienced a rare decay of the jawbone after taking the medication, known as osteonecrosis of the jaw or ONJ. However, more and more doctors and medical experts are now noticing a possible connection between non-impact femur fractures and broken bones from Fosamax.
An ABC News and World Report aired last night discussing the stories of several women who have experienced these spontaneous broken bones and fractures after using the Fosamax for several years. Research into the Fosamax femur fracture side effects suggest that prolonged use of the osteoporosis drug may overly suppress bone metabolism, impacting the ability of the bone to repair microdamage to the femur (thigh bone), which is one of the strongest in the body.
The ABC report highlights how users and the medical community have not been adequately warned about the risk of femur fracture from Fosamax. The FDA told ABC that they are looking into the reports of bone breaks with Fosamax, and Merck issued a statement for the report denying that any causal connection has been established.
Here is the Fosamax femur fracture video from ABC News:
Similar stories continue to turn up about these unexplained Fosamax thigh bone fractures, which can occur after no obvious trauma. The following news report by WCBD-TV, a local NBC Affiliate in Charleston, South Carolina, aired last month:
FOSAMAX FEMUR FRACTURE ATTORNEYS
If you, a friend or family member have suffered a broken thigh bone or femur fracture on Fosamax, you may have a case as a result of Merck’s failure to warn about the potential risk. Fosamax fracture lawsuits are reviewed for users of the drug throughout the United States, and there are no fees or expenses unless a recovery is obtained. To have a case reviewed by one of our Fosamax attorneys, request a free consultation and claim evaluation.
Medical Malpractice Litigation Is Not The Issue, Patient Safety Is
In the recent debate over heath care reform, Republicans have attempted to put the focus on medical malpractice litigation and diminishing the rights of victims to be compensated for preventable medical errors. However, the real issue in the debate should be about patient safety and making medical care in America better, safer and more effective, which medical malpractice limits will not accomplish.
Yasmin / Yaz Litigation Update: Preservation Order
Plaintiffs and defendants involved in litigation over Yaz and Yasmin birth control in federal courts have been ordered to preserve all evidence that may be relevant to the cases. The lawyers at Saiontz & Kirk, P.A. represent women throughout the United States who are pursuing a Yaz lawsuit, Yasmin lawsuit or Ocella lawsuit as a result of serious and potentially life-threatening side effects of the drugs. It is important that all individuals with potential claims take steps to preserve certain evidence that is in their possession.
>>INFORMATION: Yaz and Yasmin Litigation
More than 26,000 Lawsuits Over Seroquel Pending As First Trial Gets Underway
Among Seroquel lawyers, all eyes are on New Jersey state court, where the first trial over AstraZeneca’s failure to warn users about the risk of diabetes from Seroquel is underway. This is the first trial out of more than 26,000 lawsuits over Seroquel filed across the country by users who suffered injuries like diabetes, pancreatitis and a rare movement disorder known as tardive dyskinesia.
St. Joseph Stent Problems Continue for Towson Hospital
On top of mounting lawsuits over stent procedures by Dr. Mark Midei and tarnished public trust, St. Joseph Medical Center is now the target of a congressional probe into whether the unnecessary operations were an intentional effort to defraud American taxpayers.
>>MORE INFORMATION: St. Joseph Stent Problems with Dr. Midei
Avandia Recall Lawyers: Senate Report Backs Up Calls to Recall Avandia
A new Senate report says that GlaxoSmithKline was well aware of the potential heart side effects of Avandia, yet failed to take steps to warn doctors or protect the public. In a 342-page report from the Senate Finance Committee, congressional investigators blast the drug maker and back up nearly three years of calls for regulators to issue an Avandia recall.
>>INFORMATION: Saiontz & Kirk Avandia Blog Posts
Super Poligrip Recall: GlaxoSmithKline to Remove Zinc from Denture Adhesives
Facing increasing pressure from zinc poisoning lawsuits and critics calling for a Super Poligrip recall, GlaxoSmithKline has announced that it will discontinue all Super Poligrip denture adhesives that contain zinc.
>>INFORMATION: Super Poligrip Zinc Poisoning Lawsuits
